MONEX GROUP

Oasis says it opposes Taisho Pharma's $5 bln management buyout

The Japanese firm's founding family gained 73% of the company in a tender offer last month for 8,620 yen per share - in the country's largest management buyout to date. That represented a 55% premium to Taisho's share price before the offer was announced but was still below book value.